Abstract | PURPOSE: METHODS: RESULTS: Of the 41 patients, 39 experienced diarrhea. Compared with the control group, the TJ-14 group showed a significant improvement in diarrhea grades ( P=0.044) as well as a reduced frequency of diarrhea grades 3 and 4 (one patient versus ten patients; P=0.018). However, the two groups showed no differences in the frequency of diarrhea or the number of days the symptoms continued. This study was stopped at an interim evaluation. CONCLUSION:
TJ-14 was effective in preventing and controlling CPT-11-induced diarrhea.
|
Authors | Kiyoshi Mori, Tetsuro Kondo, Yukari Kamiyama, Yasuhiko Kano, Keigo Tominaga |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 51
Issue 5
Pg. 403-6
(May 2003)
ISSN: 0344-5704 [Print] Germany |
PMID | 12687289
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Drugs, Chinese Herbal
- hange-shashinto
- Irinotecan
- Cisplatin
- Camptothecin
|
Topics |
- Adult
- Aged
- Antineoplastic Agents, Phytogenic
(adverse effects, therapeutic use)
- Camptothecin
(adverse effects, analogs & derivatives, therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy)
- Cisplatin
(therapeutic use)
- Diarrhea
(chemically induced, prevention & control)
- Drugs, Chinese Herbal
(pharmacology)
- Female
- Humans
- Irinotecan
- Lung Neoplasms
(drug therapy)
- Male
- Medicine, Kampo
- Middle Aged
- Treatment Outcome
|